Ampatzis Christos, Zervoudis Stefanos, Eskitzis Panagiotis, Tsikouras Panagiotis, Papakonstantinou Anthi, Iatrakis Georgios
Rural doctor, G. H. Krestena, Ilia, Greece.
Rea Maternity Hospital: Breast Unit, Athens, Greece.
Maedica (Bucur). 2025 Jun;20(2):353-357. doi: 10.26574/maedica.2025.20.2.353.
We decided to do a literature search for information about the clinical significance of micrometastases (pN1mi) and isolated tumor cells (ITCs). A detailed search was conducted in the existing bibliography. We found that pN1mi and ITCs had differences in prognosis and were handled in a different way. However, some researchers do not accept this difference. Many studies have shown no differences in their prognosis and the distinction of these terms is questioned. This fact is attributed to different definitions, diagnostic approaches that have been used and not well organised research. For their diagnosis, single hematoxylin and eosin (H) stain slide section, and not routine immunohistochemical (IHC) stain, is recommended, despite a lot of institutions perform multiple level sections and IHC stains for each block of sentinel lymph nodes (SLNs). Once the limits within pN1mi and ITCs were defined, they have been based in small data, and here is an area where we should focus and build evidence based definitions that have proven differences and importance in clinical management. As for their therapy, in ITCs cases, axillary lymph node dissection (ALND) is omitted, but a large amount of data questions the safety of this omission. In pN1mi cases, ALND is performed.
我们决定进行文献检索,以获取有关微转移(pN1mi)和孤立肿瘤细胞(ITC)临床意义的信息。我们在现有文献中进行了详细检索。我们发现pN1mi和ITC在预后方面存在差异,且处理方式不同。然而,一些研究人员不接受这种差异。许多研究表明它们在预后方面没有差异,这些术语的区分受到质疑。这一事实归因于不同的定义、所采用的诊断方法以及研究组织不完善。对于它们的诊断,尽管许多机构对每个前哨淋巴结(SLN)块进行多层切片和免疫组化(IHC)染色,但建议使用单一苏木精和伊红(H)染色切片,而非常规免疫组化染色。一旦确定了pN1mi和ITC的界限,它们是基于少量数据的,而这是我们应该关注并建立基于证据的定义的领域,这些定义在临床管理中已证明存在差异且具有重要性。至于它们的治疗,在ITC病例中,省略腋窝淋巴结清扫术(ALND),但大量数据对这种省略的安全性提出了质疑。在pN1mi病例中,则进行ALND。